High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$257K
$257,688
Total Sells (Filtered)
$84.7M
$84,662,132
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
JNJ
M
JOHNSON & JOHNSON
Decker Robert J
• Officer • VP Corporate Controller
Other
2026-02-27
$471,355
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • VP Corporate Controller
Other
|
2026-02-27 | $471,355 | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Decker Robert J
• Officer • VP Corporate Controller
Discretionary SellΔOwn -14.7%
2026-02-27
$1,010,070Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • VP Corporate Controller
Discretionary SellΔOwn -14.7%
|
2026-02-27 | $1,010,070Large | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Chair
Discretionary Sell
|
2026-02-20 | $324,763 | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Chair
Other
|
2026-02-18 | $1,576,004Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Schmid Timothy
• Chair
Discretionary SellΔOwn -25.2%
2026-02-18
$2,200,281Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Chair
Discretionary SellΔOwn -25.2%
|
2026-02-18 | $2,200,281Large | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Chair
Other
|
2026-02-18 | $1,165,331Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Schmid Timothy
• Chair
Discretionary SellΔOwn -33.7%
2026-02-18
$3,327,225Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Chair
Discretionary SellΔOwn -33.7%
|
2026-02-18 | $3,327,225Large | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Wolk Joseph J
• CFO
Discretionary SellΔOwn -23.6%
2026-02-17
$2,930,469Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CFO
Discretionary SellΔOwn -23.6%
|
2026-02-17 | $2,930,469Large | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -62.7%
2026-02-17
$5,278,203Whale
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -62.7%
|
2026-02-17 | $5,278,203Whale | S | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Other
2026-02-17
$4,673,101Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Other
|
2026-02-17 | $4,673,101Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -69.8%
2026-02-17
$7,272,261Whale
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -69.8%
|
2026-02-17 | $7,272,261Whale | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
2026-02-17
$554,769
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
|
2026-02-17 | $554,769 | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
CFO
Other
|
2026-02-17 | $2,225,606Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Wolk Joseph J
• CFO
Discretionary SellΔOwn -33.1%
2026-02-17
$4,675,371Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CFO
Discretionary SellΔOwn -33.1%
|
2026-02-17 | $4,675,371Large | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
CFO
Other
|
2026-02-17 | $1,562,668Large | M | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
CFO
Other
|
2026-02-17 | $4,404,949Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Wolk Joseph J
• CFO
Discretionary SellΔOwn -46.1%
2026-02-17
$8,104,452Whale
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CFO
Discretionary SellΔOwn -46.1%
|
2026-02-17 | $8,104,452Whale | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Wolk Joseph J
• CFO
Discretionary SellΔOwn -64.1%
2026-02-17
$6,057,535Whale
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CFO
Discretionary SellΔOwn -64.1%
|
2026-02-17 | $6,057,535Whale | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Other
|
2026-02-17 | $3,378,167Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Swanson James D.
• Officer • EVP, CIO
Discretionary SellΔOwn -44.4%
2026-02-17
$4,980,447Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Discretionary SellΔOwn -44.4%
|
2026-02-17 | $4,980,447Large | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Broadhurst Vanessa
• Officer • EVP, Global Corp Affairs
Discretionary SellΔOwn -21.2%
2026-02-17
$1,508,288Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Global Corp Affairs
Discretionary SellΔOwn -21.2%
|
2026-02-17 | $1,508,288Large | S | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Other
2026-02-17
$3,430,180Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Other
|
2026-02-17 | $3,430,180Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Swanson James D.
• Officer • EVP, CIO
Discretionary SellΔOwn -47.0%
2026-02-13
$5,408,169Whale
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Discretionary SellΔOwn -47.0%
|
2026-02-13 | $5,408,169Whale | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Other
|
2026-02-13 | $3,212,958Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Swanson James D.
• Officer • EVP, CIO
Discretionary SellΔOwn -43.6%
2026-02-13
$4,721,144Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Discretionary SellΔOwn -43.6%
|
2026-02-13 | $4,721,144Large | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Other
|
2026-02-13 | $3,611,585Large | M | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
Mulholland Kristen
• Officer • EVP, Chief HR Officer
Other
2026-02-06
$573,019
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Chief HR Officer
Other
|
2026-02-06 | $573,019 | M | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
Wengel Kathryn E
• Officer • EVP, Chief TO and Risk Officer
Other
2026-02-06
$3,967,327Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Chief TO and Risk Officer
Other
|
2026-02-06 | $3,967,327Large | M | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Chair
Other
|
2026-02-06 | $1,586,218Large | M | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
Forminard Elizabeth
• Officer • EVP, Chief Legal Officer
Other
2026-02-05
$1,155,359Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Chief Legal Officer
Other
|
2026-02-05 | $1,155,359Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Duato Joaquin
• CEO
Discretionary SellΔOwn -61.3%
2026-01-26
$10,804,432MEGA
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CEO
Discretionary SellΔOwn -61.3%
|
2026-01-26 | $10,804,432MEGA | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Duato Joaquin
• CEO
Discretionary SellΔOwn -39.1%
2026-01-26
$11,318,461MEGA
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CEO
Discretionary SellΔOwn -39.1%
|
2026-01-26 | $11,318,461MEGA | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Director
Discretionary BuyΔOwn +208.8%
|
2025-11-26 | $257,688 | P | Form 4 |
|
JNJ
M
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Other
2025-10-17
$3,430,180Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Other
|
2025-10-17 | $3,430,180Large | M | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
2025-10-17
$4,185,793Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
|
2025-10-17 | $4,185,793Large | S | Form 4 |